Wockhardt Ltd. (WOCKPHARMA)

Overview

Wockhardt Limited is a globally recognized pharmaceutical and biotechnology company that has carved a niche for itself in the manufacturing and marketing of a wide range of pharmaceutical, medicinal, and chemical products. With its foundations laid in 1967, the company has expanded its reach beyond the borders of its headquarters in Mumbai, India, to several key international markets including the United States, the United Kingdom, Switzerland, Ireland, Mexico, Russia, and others. Wockhardt prides itself on its dedication to innovation, especially in the domain of infectious diseases, where it has developed a series of molecules designed to combat such conditions. Furthermore, the company's prowess extends to the production of active pharmaceutical ingredients, showcasing its versatile capabilities in the pharmaceutical sector. Adding to its array of offerings, Wockhardt also engages in contract manufacturing services, providing a comprehensive suite of solutions to meet the diverse needs of its global clientele.

Products and Services

• Glaritus: A long-acting biosimilar of insulin glargine, Glaritus is designed to offer a reliable, extended duration of action for managing blood sugar levels in people with diabetes.
• Wosulin: This recombinant human insulin product offers a biotechnologically derived option aimed at controlling and managing diabetes by providing insulin identical to that produced in the human body.
• Wepox: An r-DNA erythropoietin, Wepox is used in the treatment of anemia associated with chronic renal failure, offering patients a synthetic form of the hormone erythropoietin to stimulate red blood cell production.
• Human Insulin: Wockhardt’s human insulin products are geared towards offering a traditional approach to insulin therapy for diabetes management, utilizing insulin derived from recombinant DNA technology.
• Biovac-B: A hepatitis B vaccine developed to provide immunization against the hepatitis B virus, Biovac-B is part of Wockhardt’s commitment to preventing infectious diseases through effective vaccination.
• Active Pharmaceutical Ingredients (APIs): Wockhardt supplies a variety of APIs, serving as the foundational components for many drugs, and exemplifying its role in the broader pharmaceutical supply chain.
• Contract Manufacturing Services: Leveraging its extensive manufacturing capabilities and quality control standards, Wockhardt offers contract manufacturing services, allowing other pharmaceutical companies to benefit from its expertise and facilities for their products.
• Novel Molecules: The company is involved in the development of novel molecules, particularly for infectious diseases, showcasing its ongoing commitment to innovation in healthcare through molecules such as WCK 5222, WCK 4282, WCK 4873, WCK 771, WCK 2349, and WCK 6777.
• Biopharmaceutical Products Pipeline: Wockhardt's pipeline includes advanced formulations and delivery devices for long-acting insulin analogues, concentrated insulins, GLP1 analogues, haemopoietins, biobetters, and novel products, indicating a forward-thinking approach to biopharmaceutical development.